Navigation Links
Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research

SAN FRANCISCO, Sept. 8 /PRNewswire/ -- Takeda San Francisco Inc. announced today that Gregory Landes, Ph.D., has joined the company as vice president of antibody research. Dr. Landes will be responsible for directing the discovery and preclinical development of therapeutic antibodies at Takeda's antibody IND engine and center of excellence for biologics.

"Greg brings over 25 years of experience in the biopharmaceutical industry and is a great addition to the Takeda San Francisco management team," said Mary Haak-Frendscho, Ph.D. president and chief scientific officer, Takeda San Francisco. "Greg's extensive experience covers key aspects of antibody drug discovery and development. He will play an important role as we expand Takeda's biologics R&D capabilities in order to realize our goals of advancing superior therapeutics to contribute to the health of individuals."

Dr. Landes previously has held executive positions with major biopharmaceutical companies, including Lexicon Pharmaceuticals, Abgenix, Inc. and Genzyme Corp, where he led antibody drug discovery, antibody development and functional genomics. He has authored more than 49 peer-reviewed publications and is co-inventor on 12 issued plus additional pending patents. He holds a BA in Chemistry and PhD in Biochemistry from the University of Kansas and was a post-doctoral scholar at UCLA.

About Takeda San Francisco

Takeda San Francisco was established in November 2007 and supports Takeda's therapeutic antibody research aiming to build antibody technology platforms based on technologies such as discovery and development of antibodies, enhancement of antibody activity and antibody-manufacturing in close collaboration with Takeda's other R&D organizations. Additional information about Takeda San Francisco is available at

About Takeda

Founded in 1781 and located in Osaka, Japan, Takeda (TSE: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website,

SOURCE Takeda San Francisco Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
2. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
3. PPD Confirms Takedas NDA Filing of Alogliptin with U.S. Food and Drug Administration
4. Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
5. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
6. Takeda Pharmaceuticals Establishes $3 Million Endowment with AGA Foundation
7. Takedas Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO
8. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
9. Codexis Appoints Singapore Laboratories Managing Director
10. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
(Date:12/1/2015)... Vancouver , booth ... features Owen Mumford,s unique Comfort Zone Technology®. --> ... is a touch activated lancet that features Owen Mumford,s ... a leading medical device manufacturer, today unveils a new ... in the US before expanding out to other markets. ...
(Date:12/1/2015)... , Dec. 1, 2015 Today the Allen ... Seattle,s South Lake Union neighborhood, ... of Mercer Street and Westlake Avenue North, the 270,000 ... Allen Institute for Brain Science and the Allen Institute ... philanthropist and founder of the Allen Institute. "We started ...
(Date:12/1/2015)... , Dec. 1, 2015 Researchers at ... McGovern Institute for Brain Research at MIT have engineered ... significantly cut down on "off-target" editing errors. The refined ... the use of genome editing. Science , ... changing three of the approximately 1,400 amino acids that ...
(Date:12/1/2015)...  Twist Bioscience, a company focused on synthetic DNA, today ... been selected as one of Foreign Policy,s 100 ... blocks of life . Each year, Foreign Policy ... work have changed lives and are shaping the world. ... honor to be recognized among these incredible global leaders," said ...
Breaking Biology Technology:
(Date:11/18/2015)... 2015 --> ... market report titled  Gesture Recognition Market - Global Industry ... 2021. According to the report, the global gesture recognition market was valued ... reach US$29.1 bn by 2021, at a CAGR of ... America dominated the global gesture recognition market ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing need ... analytical tools has been paving the way for ... determination of discrete analytes in clinical, agricultural, environmental, ... being predominantly used in medical applications, however, their ... sectors due to continuous emphasis on improving product ...
Breaking Biology News(10 mins):